Eyetech to Present at Morgan Stanley's Third Annual Global Healthcare Unplugged Conference

Eyetech to Present at Morgan Stanley's Third Annual Global
Healthcare Unplugged Conference 


NEW YORK, April 21  /PRNewswire-FirstCall/ -- Eyetech Pharmaceuticals, Inc.
(NASDAQ:EYET) today announced that it will present at Morgan Stanley's Third
Annual Healthcare Unplugged Conference in Miami, Florida on Thursday, May 5,
2005 at 9:30 a.m. Eastern Time.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20050407/EYETLOGO )

Interested parties may access a live audio webcast of the presentation by
logging on to the Investor Relations section of our corporate website at
http://www.eyetech.com/.  An archived version of the webcast will be available
at both locations through May 12, 2005.

About Eyetech Pharmaceuticals, Inc.

Eyetech Pharmaceuticals, Inc. is a biopharmaceutical company that specializes
in the development and commercialization of novel therapeutics to treat
diseases of the eye.  Eyetech's initial focus is on diseases affecting the back
of the eye.  Eyetech is commercializing and further developing Macugen(R)
(pegaptanib sodium injection) with Pfizer Inc for the treatment of neovascular
AMD.  Macugen is also being studied for the treatment of diabetic macular edema
and retinal vein occlusion. 

http://www.newscom.com/cgi-bin/prnh/20050407/EYETLOGODATASOURCE: Eyetech
Pharmaceuticals, Inc.



CONTACT:  Investors, Glenn Sblendorio, Chief Financial Officer,

[phone], or fax, [phone], ; or

Media, Chris Smith, Public Relations & Corporate Communications,

[phone], or fax, [phone], , both of

Eyetech Pharmaceuticals



Web site:  http://www.eyetk.com/ 

Copyright